Aetna Receives Average Recommendation of “Buy” from Analysts (NYSE:AET)
Aetna (NYSE:AET) has been given an average rating of “Buy” by the eighteen ratings firms that are covering the stock, American Banking News reports. Five analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $86.00.
Aetna (NYSE:AET) opened at 76.74 on Monday. Aetna has a 1-year low of $60.32 and a 1-year high of $85.72. The stock’s 50-day moving average is $81.58 and its 200-day moving average is $75.2. The company has a market cap of $27.212 billion and a P/E ratio of 13.42.
Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.69 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.61 by $0.08. The company had revenue of $14.50 billion for the quarter, compared to the consensus estimate of $13.98 billion. During the same quarter last year, the company posted $1.52 earnings per share. Aetna’s revenue was up 25.3% compared to the same quarter last year. Analysts expect that Aetna will post $6.58 EPS for the current fiscal year.
A number of research firms have recently commented on AET. Analysts at Goldman Sachs downgraded shares of Aetna from a “buy” rating to a “neutral” rating in a research note on Thursday. They now have a $88.00 price target on the stock, down previously from $94.00. Separately, analysts at Leerink Swann raised their price target on shares of Aetna from $83.00 to $90.00 in a research note on Thursday, July 31st. They now have an “outperform” rating on the stock. Finally, analysts at Barclays reiterated an “overweight” rating on shares of Aetna in a research note on Wednesday, July 30th. They now have a $95.00 price target on the stock, up previously from $87.00.
Aetna Inc (NYSE:AET), is a diversified healthcare benefits company.
Receive News & Ratings for Aetna Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.